Attendee List released for Biosimilars and Biobetters | Network with Sandoz, Boehringer Ingelheim, Sanofi, Teva, Mundipharma International, AbbVie, Orion Corporation and more

SMi's Biosimilars and Biobetters conference, taking place on 30 September - 1 October 2015 in London, will address pharmacovigilance of biosimilars, patent litigation, market access, product commercialisation barriers and global market developments. End Quote

(1888PressRelease) September 11, 2015 - In just 3 weeks, SMi will open its doors to the 6th annual Biosimilars and Biobetters conference. The two-day event will provide the ideal platform to engage in scientific discussions and debate the best practices and solutions to improve industry performance. As well as learning from your peers through case studies and interactive debate, don't miss the opportunity to hear from specialists representing big pharma, academia and biotech, for important updates in the field.

Is your name on the list? Download the 2015 attendee list to take a look at who you can network with at http://www.biosimilars-biobetters.co.uk/1888pressrelease

Featured Speakers include:
• Richard DiCicco, Chairman, Harvest Moon Pharmaceuticals USA, Inc. (he's dropped out and unity's updated)
• Shahin Kauser, Senior Scientific Assessor, MHRA
• Chris Teale, Vice President Europe, GfK NOP Ltd
• Bracha Timan, Director, Israel Site Head, Global Bioassays & Technology, Global R&D, Teva
• Takashi Kei Kishimoto, Chief Scientific Officer, Selecta Biosciences
• Karsten Roth, Director Clinical Operations, Cinfa Biotech GmbH
• Alan Sheppard, Principal, Global Generics and Biosimilars, IMS Health
• Steinar Madsen, Medical Director, Norwegian Medicines Agency

View the full speaker line-up, complete two-day conference programme and download the event brochure at http://www.biosimilars-biobetters.co.uk/1888pressrelease

Why do I need to be there?
• Hear the latest on the evolving regulatory landscape for biosimilars and review the guidelines
• Gain understanding on the barriers being faced for market access and commercialisation of products through case-study led presentations
• Focus on the global market developments with case studies on emerging markets of biosimilars and examine the trends we are currently seeing
• Assess and review in-depth protein characterisation and analytical comparability to efficiently and effectively collect data

Plus, don't miss two interactive conference workshops:
Workshop A | 1:00pm - 5.30pm | 29th September 2015
Assessing the Regulatory Framework for Europe and the US - Developing Future Biologics
Workshop Leaders: Lincoln Tsung, Daniel Kracov, Jennifer Sklenar, Partners, Arnold & Porter (UK) LLP

Workshop B | 8:30am - 12.30pm | 2nd October 2015
Biosimilars - Understanding the Regulatory Processes and the Commercial Realities
Workshop Leader: Peter Wittner, Senior Consultant, Interpharm Consultancy

###

space

Other Related Press Releases